Skip to main content

Advertisement

Log in

Cerebrotendinous xanthomatosis: Neuropathological findings

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Cerebrotendinous xanthomatosis is an inherited autosomal recessive lipid storage disease caused by a 27-hydroxylase enzyme deficiency, characterised clinically by tendon xanthomas, premature cataracts, chronic diarrhoea and progressive neurologic dysfunction. The disease is very uncommon and there are very few pathological descriptions. We report a 52-year-old male who presented with a neuropsychiatric disorder and cognitive decline. Despite treatment the patient developed optic atrophy, parkinsonism and dementia and died. The autopsy revealed a nonspecific brain and cerebellar atrophy.Under microscopic examination, lipid crystal clefts, neuronal loss, demyelination, reactive astrocytosis and perivascular macrophages were found. These findings suggest the limited reversibility of the disease, and its poor prognosis, specially if treatment is not started early.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arpa J, Sanchez C, Vega A, Cruz-Martinez A, Ferrer T, Lopez-Pajares R, Munoz J, Barreiro P (1995) Cerebrotendinous xanthomatosis diagnosed after traumatic subdural haematoma. Rev Neurol 23:675–678

    PubMed  CAS  Google Scholar 

  2. Barkhof F, Verrips A, Wesseling P, Der Knaap MS, van Engelen BG, Gabreels F J, Keyser A, Wevers RA, Valk J (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217:869–876

    PubMed  CAS  Google Scholar 

  3. Campdelacreu J, Munoz E, Cervera A, Jauma S, Giros M, Tolosa E (2002) Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases. Neurologia 17:647–650

    PubMed  CAS  Google Scholar 

  4. Cuende E, Gomez-Rz dM, Vesga JC, Saracibar N, Ibanez-Aviles A, Castellano-Hurtado C (1996) Cerebrotendinous xanthomatosis: utility of nuclear magnetic resonance image in the follow-up and response to treatment. Rev Neurol 24:1535–1538

    PubMed  CAS  Google Scholar 

  5. De Stefano N, Dotti MT, Mortilla M, Federico A (2001) Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 124:121–131

    Article  PubMed  CAS  Google Scholar 

  6. Kato H, Koyabu S, Aoki S, Tamai T, Sugawa M, Watanabe M, Shiraishi T (2003) An autopsy case of gallbladder cancer developing in a Japanese man with cerebrotendinous xanthomatosis: genetic analysis of the sterol 27-hydroxylase and p53 genes. Pathology 35:41–144

    Article  Google Scholar 

  7. Leitersdorf E, Reshef A, Meiner V, Levitzki R, Schwartz SP, Dann EJ, Berkman N, Cali JJ, Klapholz L, Berginer VM (1993) Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest 91:2488–2496

    Article  PubMed  CAS  Google Scholar 

  8. Moghadasian MH (2004) Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med 27:42–50

    PubMed  CAS  Google Scholar 

  9. Moghadasian MH, Salen G, Frohlich JJ, Scudamore CH (2002) Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Arch Neurol 59:527–529

    Article  PubMed  Google Scholar 

  10. Soffer D, Benharroch D, Berginer V (1995) The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol (Berl) 90:213–220

    Article  PubMed  CAS  Google Scholar 

  11. Sperhake JP, Matschke J, Orth U, Gal A, Puschel K (2000) Sudden death due to cerebrotendinous xanthomatosis confirmed by mutation analysis. Int J Legal Med 113:110–113

    Article  PubMed  CAS  Google Scholar 

  12. Sugama S, Kimura A, Chen W, Kubota S, Seyama Y, Taira N, Eto Y (2001) Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27). J Inherit Metab Dis 24:379–392

    Article  PubMed  CAS  Google Scholar 

  13. Verrips A, Hoefsloot LH, Steenbergen GC, Theelen JP, Wevers RA, Gabreels FJ, van Engelen BG, van den Heuvel LP (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123:908–919

    Article  PubMed  Google Scholar 

  14. Verrips A, van Engelen BG, Wevers RA, van Geel BM, Cruysberg JR, van den Heuvel LP, Keyser A, Gabreels FJ (2000) Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. Arch Neurol 57:520–524

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Pilo de la Fuente.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pilo de la Fuente, B., Ruiz, I., Lopez de Munain, A. et al. Cerebrotendinous xanthomatosis: Neuropathological findings. J Neurol 255, 839–842 (2008). https://doi.org/10.1007/s00415-008-0729-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0729-6

Key words

Navigation